Jazz Pharmaceuticals (JAZZ) Net Margin (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly Net Margin of 27.42% for Q1 2026, up 3771.0% year-over-year from 0.71% in Q1 2025, and up 61.4% quarter-over-quarter from 16.99% in Q4 2025.
Powered by 
Analysis
Jazz Pharmaceuticals (JAZZ) Net Margin (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Net Margin history runs 16 years deep, the most recent figure standing at 27.42% for Q1 2026.
- In Q1 2026, Net Margin rose 3771.0% year-over-year to 27.42%; the TTM figure through Mar 2026 stood at 0.67% (down 1121.0% YoY), while the FY2025 annual figure was 8.33%, down 2213.0% from the prior year.
- Net Margin for Q1 2026 stood at 27.42%, up from 16.99% in the prior quarter.
- The five-year high for Net Margin was 27.42% in Q1 2026, with the low at 68.7% in Q2 2025.
- The 5-year median for Net Margin is 9.35% (2023), against an average of 3.66%.
- The sharpest annual moves came in 2022 and 2025: Net Margin surged 5248 bps in 2022, then slumped 8517 bps in 2025.
- Jazz Pharmaceuticals' Net Margin stood at 24.68% in 2022, then jumped by 138 bps to 9.35% in 2023, then soared by 88 bps to 17.57% in 2024, then slipped by 3 bps to 16.99% in 2025, then jumped by 61 bps to 27.42% in 2026.
- Business Quant data shows JAZZ's Net Margin at 27.42% in Q1 2026, 16.99% in Q4 2025, and 22.33% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -539.31% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 13.90% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 12.74% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -3.12% |
| 10 | Jazz Pharmaceuticals | 15.60 Bn | 13.98 Bn | 1.09 Bn | 15.96% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.96% |
| Mar 31, 2026 | 27.42% |
| Dec 31, 2025 | 16.99% |
| Sep 30, 2025 | 22.33% |
| Jun 30, 2025 | -68.70% |
| Mar 31, 2025 | -10.29% |
| Dec 31, 2024 | 17.56% |
| Sep 30, 2024 | 20.41% |
| Jun 30, 2024 | 16.47% |
| Mar 31, 2024 | -1.63% |
| Dec 31, 2023 | 9.35% |
| Sep 30, 2023 | 15.09% |
| Jun 30, 2023 | 11.08% |
| Mar 31, 2023 | 7.89% |
| Dec 31, 2022 | -24.68% |
| Sep 30, 2022 | -1.82% |
| Jun 30, 2022 | 3.98% |
| Mar 31, 2022 | 0.71% |
| Dec 31, 2021 | -3.61% |
| Sep 30, 2021 | -5.91% |